Day: May 10, 2025

MONTREAL, May 10, 2025 (GLOBE NEWSWIRE) — DAVIDsTEA Inc. (TSX-Venture: DTEA) (“DAVIDsTEA” or the “Company”) announces with deep sadness the passing of its founder Herschel Segal in Montreal, Québec on Tuesday, May 6, 2025. Herschel Segal was a pioneering Canadian entrepreneur whose career shaped two iconic retail brands. He was the founder of Le Château, a fashion retailer that became a mainstay in Canadian shopping culture for decades. In 2008, he co-founded DAVIDsTEA, transforming the specialty tea category with a bold, modern retail concept that introduced a new generation to the world of tea. Herschel Segal brought vision, determination, and a strong belief in customer connection to every venture he led. At DAVIDsTEA, he championed accessibility, innovation, and a sense of community — principles that continue to define the...

Analysis of EFX results with AI-based digital pathology underscores the potential value in evaluating histopathology response Data contribute to growing body of support around the anti-fibrotic activity of EFX in patients with pre-cirrhotic MASH SOUTH SAN FRANCISCO, Calif., May 10, 2025 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic diseases marked by high unmet medical need, today announced results from new analyses of the 96-week Phase 2b HARMONY trial of efruxifermin (EFX) in patients with pre-cirrhotic (F2-F3 fibrosis) metabolic dysfunction-associated steatohepatitis (MASH) in an oral presentation and a poster presentation at the European Association for the Study of the Liver (EASL) Congress 2025 taking place May...

Late-breaking results from the open-label compensated MASH cirrhosis (F4c) arm of the Phase 3 MAESTRO-NAFLD-1 trial presented at the EASL Congress 65% of patients with clinically significant portal hypertension (CSPH) at baseline moved into lower risk categories by year two Patients achieved a mean 6.7 kPa reduction in liver stiffness, which was statistically significant compared to baselineCONSHOHOCKEN, Pa., May 10, 2025 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced positive two-year results from the open-label compensated MASH cirrhosis (F4c) arm of the Phase 3 MAESTRO-NAFLD-1 trial of Rezdiffra. Patients (n=122) in the study achieved significant improvements...

NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today announced that Shopify Inc. (Nasdaq: SHOP), will become a component of the Nasdaq-100 Index® (Nasdaq: NDX®) and the Nasdaq-100 Equal Weighted™ Index (Nasdaq: NDXE™) prior to market open on Monday, May 19, 2025. Shopify Inc. will replace MongoDB, Inc. (Nasdaq: MDB) in the Nasdaq-100 Index® and the Nasdaq-100 Equal Weighted™ Index. MongoDB, Inc. will also be removed from the Nasdaq-100 Tech Sector™ Index (Nasdaq: NDXT™), the Nasdaq-100 Technology Sector Market-Cap Weighted™ Index (NDXTMC™), the Nasdaq-100 Technology Sector Adjusted Market-Cap Weighted™ Index (NDXT10™), the Nasdaq-100 ESG™ Index (Nasdaq: NDXESG™), the Nasdaq-100 Sustainable ESG Select™ Index (Nasdaq: NDXSES™)...